H5N1 Bird Flu Diagnostic Kit Detects All Known Strains of H5N1 Virus with a Single Test
The close collaboration between scientists from the Experimental Therapeutics Centre (ETC) under the Agency for Science and Technology Research (A*STAR) and clinicians from Tan Tock Seng Hospital (TTSH) has enabled the successful development of the most comprehensive and rapid H5N1 bird flu test kit available to date. With this highly advanced kit, doctors can now rapidly detect all existing strains of the H5N1 viruses in a single test with almost 100% accuracy, within a few hours. This is a big boost to public healthcare system and a great stride forward in pandemic preparedness against this highly infectious disease worldwide.
The current gold standard for H5N1 detection recommended by the World Health Organization (WHO) is only able to detect three out of the 10 distinct genetic groups (clades 1, 2 and 3). To detect all existing strains of H5N1 with the WHO detection method would not be possible. The made-in-Singapore H5N1 test kit, which is more accurately known as the H5N1 real-time Reverse Transcription Polymerase Chain Reaction (RT-PCR) assay, is the only detection kit currently available on the market that can accurately and rapidly detect all known strains of the H5N1 Avian Influenza A virus in a single test within a matter of hours.
Co-developed by Dr Masafumi Inoue, a Senior Research Scientist and Project Director of Technology Development from ETC and Dr Timothy Barkham, a senior consultant of Laboratory Medicine from TTSH, this newly launched H5N1 test kit has been clinically validated by several hospitals in Southeast Asia.
Most read news
Other news from the department science
Get the analytics and lab tech industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
Epigenomics and BioChain enter into collaboration in China
New tool developed for DNA research - Molecular gauge to disclose function of new medications
New microplastic reference particles developed - Better comparability in microplastics studies at last
Formation of nanoparticles can now be studied molecule-by-molecule
Sysmex and bioMérieux Form a Global Partnership for Urinary Screening in Microbiology
Decoding DNA's phonebook
Mettler Toledo installs Tunable Diode Lasers (TDLs) where no TDLs have gone before
Merck and Pfizer Collaborate with Dako - Development of Companion Diagnostic for Investigational anti-PD-L1 Antibody, Avelumab
SALVE Project Enters Second Phase - Successful evaluation phase prompts University of Ulm and Carl Zeiss to continue with their joint venture to develop a high-performance transmission electron microscope
Semiconductors for Cool Computers
Licence to go where no chemist has gone before